Purchase Order 75N93024P00994
Award Date 8/14/24
Potential Completion Date 9/30/24
Potential Value $15K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $21,714.40 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer of specialized genetic research materials. The contract is for the supply of a human siRNA library to support the agency's translational sciences, experimental systems evaluation, and biomedical research initiatives. Horizon Discovery Biosciences LIMITED is a subsidiary of the medical imaging...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12,235.00 firm-fixed-price purchase order contract to Horizon Discovery Limited, a for-profit biotechnology company based in the United Kingdom. The contract is for the provision of custom human cell lines to support biomedical research, with a completion date of December 13, 2019. No set-aside was used for this award. Horizon Discovery...
- Horizon Discovery Biosciences LIMITED has been awarded a firm fixed price purchase order totaling one hundred twenty-one thousand two hundred ninety-four dollars and sixty-four cents ($121,294.64) by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to supply a Dharmacon Human On-TargetPlus Druggable Genome siRNA Library for the Functional Genomic Lab. The purchase order does not include any set-aside designations...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $202,000.00 firm fixed price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for the "SIRNAS WITH ACCELL MODIFICATION PROJECT". The contract, which does not have a small business set-aside, is for the provision of various gene silencing and regulation products, including small interfering...
- This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Horizon Discovery LIMITED, a UK-based for-profit biotechnology company. The $30,805.00 contract is for genome editing testing services, with an ultimate completion date of December 31, 2015. The contract does not have a set-aside designation....
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NIH NCATS) awarded a $122,612.40 firm fixed-price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for 14 Mouse ON-TARGET plus small interfering RNA (siRNA) libraries. This non-competitive, brand-name acquisition was conducted under simplified acquisition procedures without any small business set-aside. The purchase...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Horizon Genomics GMBH, a foreign-owned for-profit organization. The $4,160.00 firm fixed-price purchase order is for the provision of biomaterial. The contract has no set-aside designation and has an ultimate completion date of July 18, 2018. This appears to be a standalone contract award and not part of a larger vehicle. No additional details about subcontractors or...
- This federal contract award is for the procurement of a CRISPRMOD CRISPRA HUMAN SYNTHETIC SGRNA LIBRARY - PROTEIN KINASES - POOLS - 384 WELL, 0.1 NMOL LIBRARY by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The $16,134.60 firm fixed-price purchase order was awarded to Horizon Discovery Biosciences LIMITED, a foreign-owned, for-profit manufacturer of specialized genetic research materials, primarily...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $30,316.20 firm fixed price purchase order to Horizon Discovery Biosciences Limited, located in Great Britain, United Kingdom. The contract is for unspecified products or services to be delivered between July 12, 2023 and July 22, 2023 in support of NIH's efforts to enhance the development, testing, and implementation of translational sciences. Horizon...
- The National Institute of Child Health and Human Development (NICHD) awarded a $43,072.70 firm fixed-price purchase order to Horizon Discovery Biosciences LIMITED for custom CRISPR activation (CRISPRa) and CRISPR knockout (CRISPRko) synthetic single guide RNA (sgRNA) pool libraries. The award, issued on September 10, 2025, with a completion date of September 30, 2025, provides genome-wide functional genomic screening libraries to support research identifying novel phosphate transporters. The...